Literature DB >> 27050713

Discovery and Structure-Activity Relationships of the Neoseptins: A New Class of Toll-like Receptor-4 (TLR4) Agonists.

Matthew D Morin1, Ying Wang2, Brian T Jones1, Lijing Su3, Murali M R P Surakattula1, Michael Berger4, Hua Huang4, Elliot K Beutler1, Hong Zhang3, Bruce Beutler2, Dale L Boger1.   

Abstract

Herein, we report studies leading to the discovery of the neoseptins and a comprehensive examination of the structure-activity relationships (SARs) of this new class of small-molecule mouse Toll-like receptor 4 (mTLR4) agonists. The compounds in this class, which emerged from screening an α-helix mimetic library, stimulate the immune response, act by a well-defined mechanism (mouse TLR4 agonist), are easy to produce and structurally manipulate, exhibit exquisite SARs, are nontoxic, and elicit improved and qualitatively different responses compared to lipopolysaccharide, even though they share the same receptor.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27050713      PMCID: PMC4882283          DOI: 10.1021/acs.jmedchem.6b00177

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  63 in total

Review 1.  Improving vaccine performance with adjuvants.

Authors:  F R Vogel
Journal:  Clin Infect Dis       Date:  2000-06       Impact factor: 9.079

Review 2.  The interface between innate and adaptive immunity.

Authors:  Kasper Hoebe; Edith Janssen; Bruce Beutler
Journal:  Nat Immunol       Date:  2004-10       Impact factor: 25.606

Review 3.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Nat Immunol       Date:  2010-04-20       Impact factor: 25.606

Review 4.  The perfect mix: recent progress in adjuvant research.

Authors:  Bruno Guy
Journal:  Nat Rev Microbiol       Date:  2007-07       Impact factor: 60.633

5.  Crystal structures of human MD-2 and its complex with antiendotoxic lipid IVa.

Authors:  Umeharu Ohto; Koichi Fukase; Kensuke Miyake; Yoshinori Satow
Journal:  Science       Date:  2007-06-15       Impact factor: 47.728

6.  Activation of anti-hepatitis C virus responses via Toll-like receptor 7.

Authors:  Jongdae Lee; Christina C N Wu; Ki Jeong Lee; Tsung-Hsien Chuang; Kyoko Katakura; Yu-Tsueng Liu; Michael Chan; Rommel Tawatao; Michelle Chung; Carol Shen; Howard B Cottam; Michael M C Lai; Eyal Raz; Dennis A Carson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-30       Impact factor: 11.205

Review 7.  Putting endotoxin to work for us: monophosphoryl lipid A as a safe and effective vaccine adjuvant.

Authors:  C R Casella; T C Mitchell
Journal:  Cell Mol Life Sci       Date:  2008-10       Impact factor: 9.261

8.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.

Authors:  A Poltorak; X He; I Smirnova; M Y Liu; C Van Huffel; X Du; D Birdwell; E Alejos; M Silva; C Galanos; M Freudenberg; P Ricciardi-Castagnoli; B Layton; B Beutler
Journal:  Science       Date:  1998-12-11       Impact factor: 47.728

Review 9.  Vaccine adjuvants: putting innate immunity to work.

Authors:  Robert L Coffman; Alan Sher; Robert A Seder
Journal:  Immunity       Date:  2010-10-29       Impact factor: 31.745

10.  Toll-like receptor 4 (TLR4) modulation by synthetic and natural compounds: an update.

Authors:  Francesco Peri; Valentina Calabrese
Journal:  J Med Chem       Date:  2013-11-20       Impact factor: 7.446

View more
  12 in total

1.  Anticancer Mechanisms in Two Murine Bone Marrow-Derived Dendritic Cell Subsets Activated with TLR4 Agonists.

Authors:  Alexander Bagaev; Aleksey Pichugin; Edward L Nelson; Michael G Agadjanyan; Anahit Ghochikyan; Ravshan I Ataullakhanov
Journal:  J Immunol       Date:  2018-03-02       Impact factor: 5.422

Review 2.  Immunobiology and application of toll-like receptor 4 agonists to augment host resistance to infection.

Authors:  Antonio Hernandez; Naeem K Patil; Cody L Stothers; Liming Luan; Margaret A McBride; Allison M Owen; Katherine R Burelbach; David L Williams; Edward R Sherwood; Julia K Bohannon
Journal:  Pharmacol Res       Date:  2019-11-02       Impact factor: 7.658

3.  Structure-Activity Relationship Studies of Pyrimido[5,4-b]indoles as Selective Toll-Like Receptor 4 Ligands.

Authors:  Michael Chan; Yuhei Kakitsubata; Tomoko Hayashi; Alast Ahmadi; Shiyin Yao; Nikunj M Shukla; Shin-Ya Oyama; Akihito Baba; Brandon Nguyen; Maripat Corr; Yasuo Suda; Dennis A Carson; Howard B Cottam; Masahiro Wakao
Journal:  J Med Chem       Date:  2017-11-03       Impact factor: 7.446

4.  Structural Basis of TLR2/TLR1 Activation by the Synthetic Agonist Diprovocim.

Authors:  Lijing Su; Ying Wang; Junmei Wang; Yuto Mifune; Matthew D Morin; Brian T Jones; Eva Marie Y Moresco; Dale L Boger; Bruce Beutler; Hong Zhang
Journal:  J Med Chem       Date:  2019-03-13       Impact factor: 7.446

5.  Synthesis, structure-activity relationship studies and evaluation of a TLR 3/8/9 agonist and its analogues.

Authors:  Anindya Sarkar; Anushka C Galasiti Kankanamalage; Qian Zhang; Heng Cheng; Prasanna Sivaprakasam; Joseph Naglich; Chunshan Xie; Sanjeev Gangwar; Dale L Boger
Journal:  Med Chem Res       Date:  2021-05-18       Impact factor: 2.351

6.  Diprovocims: A New and Exceptionally Potent Class of Toll-like Receptor Agonists.

Authors:  Matthew D Morin; Ying Wang; Brian T Jones; Yuto Mifune; Lijing Su; Hexin Shi; Eva Marie Y Moresco; Hong Zhang; Bruce Beutler; Dale L Boger
Journal:  J Am Chem Soc       Date:  2018-10-16       Impact factor: 15.419

Review 7.  The Role of Carbohydrates in the Lipopolysaccharide (LPS)/Toll-Like Receptor 4 (TLR4) Signalling.

Authors:  Florent Cochet; Francesco Peri
Journal:  Int J Mol Sci       Date:  2017-11-03       Impact factor: 5.923

8.  S100A8 and S100A9 Promote Apoptosis of Chronic Eosinophilic Leukemia Cells.

Authors:  Ji-Sook Lee; Na Rae Lee; Ayesha Kashif; Seung-Ju Yang; A Reum Nam; Ik-Chan Song; Soo-Jung Gong; Min Hwa Hong; Geunyeong Kim; Pu Reum Seok; Myung-Shin Lee; Kee-Hyung Sung; In Sik Kim
Journal:  Front Immunol       Date:  2020-08-06       Impact factor: 7.561

Review 9.  TLR4-Targeting Therapeutics: Structural Basis and Computer-Aided Drug Discovery Approaches.

Authors:  Qurat Ul Ain; Maria Batool; Sangdun Choi
Journal:  Molecules       Date:  2020-01-31       Impact factor: 4.411

10.  Key residues in TLR4-MD2 tetramer formation identified by free energy simulations.

Authors:  Alireza Tafazzol; Yong Duan
Journal:  PLoS Comput Biol       Date:  2019-10-14       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.